Publication Beamlines Strategic Pillar
C. Baribeau, M. Sigrist (2025). Magnetic measurement of a decommissioned insertion device at the Canadian Light Source. IPAC 16, 1843-1846. 10.18429/JACoW-IPAC2025-WEPB048. Materials
Cron, Brandi; Macalady, Jennifer L.; Cosmidis, Julie (2021). Organic stabilization of extracellular elemental sulfur in a Sulfurovum-rich biofilm: a new role for EPS?. Patent Number: 10.1101/2021.06.03.446708. Environment
Fraund; Matthew; Bonanno; Daniel J.; China et al. (2020). Optical properties and composition of viscous organic particles found in the Southern Great Plains. Patent Number: 10.5194/acp-2020-255. Environment
LI, Zexia; Zhang, Mingze; Wang, Lili; LI, Yizhan (2025). A Novel Type Collaboration: Global Big Science Facilities Co-utilization. . 10.51408/issi2025_121.
Peng, Hongwei; Bai, Penghui; Lu, Yuan; Zhu, Ning; Yang, Chen et al. (2025). The influence of scale inhibitor SAS/AA/AMPS on CO2 corrosion behavior of N80 steel in simulated produced water. Patent Number: 10.2139/ssrn.5472438. Materials
S. Saadat, M. Boland, P. Kallakuri (2025). Multimethod signal processing for comprehensive tune coupling characterization at Canadian Light Source. IPAC 16, 2909-2912. 10.18429/JACoW-IPAC2025-THPM106. Materials
Yasaman Yousefi Sigari, Drew Bertwistle, Mark Boland (2021). Vertical Phase Space Measurement Progress at Canadian Light Source. Canada: University of Saskatchewan. 10.18429/JACoW-IPAC2021-MOPAB310. Materials
Denis Spasyuk (2025). XASDB - Design and Implementation of an Open-Access Spectral Database. SK, Canada: Canadian Light Source. https://arxiv.org/abs/2509.13566. Materials
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.